• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR NC TREK CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR NC TREK CORONARY DILATATION CATHETER Back to Search Results
Model Number 1012454-08
Medical Device Problem Codes Deflation Problem (1149); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/27/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that during device preparation of the 4.50x8mm nc trek balloon dilatation catheter (bdc), there was no difficulty removing the protective sheath.The bdc was prepped (air aspiration) outside the patient anatomy and the contrast mix was 90 saline/10 contrast.The procedure was performed to treat a lesion in left anterior descending (lad) coronary artery with moderate calcification.The bdc was advanced to the target lesion and inflated; however, when attempting to deflate the balloon after the first inflation the balloon did not completely deflate; even though, the balloon was held at negative pressure for at least 15 seconds.In order to remove the partially deflated balloon, the bdc was yanked from the patient anatomy.There was no adverse patient effect and no clinically significant delay reported in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Visual and functional inspections were performed on the returned device.The reported deflation issue was unable to be confirmed as deflation times were measured 3 times and were within specifications a review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history of the reported lot did not indicate a lot specific quality issue.It was reported by the account that the balloon was removed partially inflated.It should be noted the coronary dilatation catheters (cdc), nc trek rx, global, instruction for use (ifu) states: withdraw the deflated dilatation catheter and guide wire from the guiding catheter through the hemostatic valve.In this case, the ifu violation did not contributed to the reported difficulty and was necessary given the clinical situation.In addition, it was reported that the contrast mix used in the procedure was 90% saline/ 10% contrast.It should be noted that the ifu specifies that the contrast is 60% contrast medium diluted 1:1 with normal saline.In this case, since the contrast ratio used was less than the required percentage it is unknown if the ifu violation caused or contributed to the reported complaint.The investigation was unable to determine a conclusive cause for the reported deflation issue.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC TREK CORONARY DILATATION CATHETER
Common Device Name
CORONARY DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15056414
Report Number2024168-2022-07894
Device Sequence Number4667496
Product Code LOX
UDI-Device Identifier08717648152092
UDI-Public08717648152092
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
PMA/510(K) Number
K103153
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2025
Device Model Number1012454-08
Device Catalogue Number1012454-08
Device Lot Number20430G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/29/2022
Supplement Date Received by Manufacturer09/28/2022
Initial Report FDA Received Date07/19/2022
Supplement Report FDA Received Date09/30/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/30/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-